Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

被引：0

作者：

Peter A Fasching

Katharina Heusinger

Lothar Haeberle

Melitta Niklos

Alexander Hein

Christian M Bayer

Claudia Rauh

Ruediger Schulz-Wendtland

Mayada R Bani

Michael Schrauder

Laura Kahmann

Michael P Lux

Johanna D Strehl

Arndt Hartmann

Arno Dimmler

Matthias W Beckmann

David L Wachter

机构：

[1] University of California at Los Angeles,Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine

[2] Erlangen University Hospital,Department of Gynecology and Obstetrics

[3] Erlangen University Hospital,Institute of Diagnostic Radiology

[4] Erlangen University Hospital,Institute of Pathology

[5] St Vincentius Hospital,Institute of Pathology

来源：

BMC Cancer | / 11卷

关键词：

Overall Survival; Trastuzumab; Molecular Subtype; HER2 Status; Molecular Subgroup;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Fasching, Peter A.
Heusinger, Katharina
Haeberle, Lothar
Niklos, Melitta
Hein, Alexander
Bayer, Christian M.
Rauh, Claudia
Schulz-Wendtland, Ruediger
Bani, Mayada R.
Schrauder, Michael
Kahmann, Laura
Lux, Michael P.
Strehl, Johanna D.
Hartmann, Arndt
Dimmler, Arno
Beckmann, Matthias W.
Wachter, David L.
BMC CANCER, 2011, 11
[2] KI67 AS A PREDICTOR OF CLINICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN TRIPLEPOSITIVE BREAST CANCER
Ben Hamida, Karim
Houcine, Yoldez
Maaoui, Amal
Hamza, Khedija
Kamoun, Salma
Ayadi, Senda
Chargui, Riadh
Driss, Maha
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A59 - A59
[3] Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
von Minckwitz, Gunter
Schmitt, Wolfgang D.
Loibl, Sibylle
Mueller, Berit M.
Blohmer, Jens U.
Sinn, Bruno V.
Eidtmann, Holger
Eiermann, Wolfgang
Gerber, Bernd
Tesch, Hans
Hilfrich, Joern
Huober, Jens
Fehm, Tanja
Barinoff, Jana
Ruediger, Thomas
Erbstoesser, Erhard
Fasching, Peter A.
Karn, Thomas
Mueller, Volkmar
Jackisch, Christian
Denkert, Carsten
CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4521 - 4531
[4] Evaluation of pretherapeutic Ki67 as predictive marker for response to neoadjuvant chemotherapy in patients with primary breast cancer.
Farr, Alex
Weber, Myriam
Pfeiler, Georg
Oppolzer, Elisabeth
Salama, Mohammed
Bago-Horvath, Zsuzsanna
Seifert, Michael
Singer, Christian F.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[5] Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Kim, Kwan Il
Lee, Kyung Hee
Kim, Tae Ryung
Chun, Yong Soon
Lee, Tae Hoon
Park, Heung Kyu
JOURNAL OF BREAST CANCER, 2014, 17 (01) : 40 - 46
[6] Factors Predicting Response in Breast Cancer Receiving Neoadjuvant Therapy and the Role of Ki67 Labeling Index
Ekinci, Ferhat
Uzun, Mehmet
Demir, Bilgin
Unek, Ilkay Tugba
Erdogan, Atike Pinar
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (08): : 872 - 878
[7] Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
Tanei, T.
Shimomura, A.
Shimazu, K.
Nakayama, T.
Kim, S. J.
Iwamoto, T.
Tamaki, Y.
Noguchi, S.
EJSO, 2011, 37 (02): : 155 - 161
[8] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
Jones, Robin L.
Salter, Janine
A'Hern, Roger
Nerurkar, Ash
Parton, Marina
Reis-Filho, Jorge S.
Smith, Ian E.
Dowsett, Mitchell
BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 53 - 68
[9] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
Robin L. Jones
Janine Salter
Roger A’Hern
Ash Nerurkar
Marina Parton
Jorge S. Reis-Filho
Ian E. Smith
Mitchell Dowsett
Breast Cancer Research and Treatment, 2009, 116 : 53 - 68
[10] The study of tumor regression mode, Ki67 expression and neoadjuvant chemotherapy on prognosis of different molecular breast cancer
Liu, Xiangjuan
Zhao, Jun
Li, Jian
Wang, Yuan
Zang, Hongyan
MINERVA SURGERY, 2023,

← 1 2 3 4 5 →